Literature DB >> 12607004

MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways.

Zhenkun Lou1, Katherine Minter-Dykhouse, Xianglin Wu, Junjie Chen.   

Abstract

Forkhead-homology-associated (FHA) domains function as protein-protein modules that recognize phosphorylated serine/threonine motifs. Interactions between FHA domains and phosphorylated proteins are thought to have essential roles in the transduction of DNA damage signals; however, it is unclear how FHA-domain-containing proteins participate in mammalian DNA damage responses. Here we report that a FHA-domain-containing protein-mediator of DNA damage checkpoint protein 1 (MDC1; previously known as KIAA0170)--is involved in DNA damage responses. MDC1 localizes to sites of DNA breaks and associates with CHK2 after DNA damage. This association is mediated by the MDC1 FHA domain and the phosphorylated Thr 68 of CHK2. Furthermore, MDC1 is phosphorylated in an ATM/CHK2-dependent manner after DNA damage, suggesting that MDC1 may function in the ATM-CHK2 pathway. Consistent with this hypothesis, suppression of MDC1 expression results in defective S-phase checkpoint and reduced apoptosis in response to DNA damage, which can be restored by the expression of wild-type MDC1 but not MDC1 with a deleted FHA domain. Suppression of MDC1 expression results in decreased p53 stabilization in response to DNA damage. These results suggest that MDC1 is recruited through its FHA domain to the activated CHK2, and has a critical role in CHK2-mediated DNA damage responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12607004     DOI: 10.1038/nature01447

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  138 in total

1.  DNA damage response signaling triggers nuclear localization of the chicken anemia virus protein Apoptin.

Authors:  Thomas J Kucharski; Isabelle Gamache; Ole Gjoerup; Jose G Teodoro
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2.

Authors:  Marshall Urist; Tomoaki Tanaka; Masha V Poyurovsky; Carol Prives
Journal:  Genes Dev       Date:  2004-12-15       Impact factor: 11.361

3.  BRCA1 and BRCA2 in breast cancer predisposition and recombination control.

Authors:  Ralph Scully; Anyong Xie
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

4.  Control of sister chromatid recombination by histone H2AX.

Authors:  Anyong Xie; Nadine Puget; Inbo Shim; Shobu Odate; Ingeborga Jarzyna; Craig H Bassing; Frederick W Alt; Ralph Scully
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

5.  RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly.

Authors:  Michael S Y Huen; Robert Grant; Isaac Manke; Kay Minn; Xiaochun Yu; Michael B Yaffe; Junjie Chen
Journal:  Cell       Date:  2007-11-20       Impact factor: 41.582

Review 6.  Twilight effects of low doses of ionizing radiation on cellular systems: a bird's eye view on current concepts and research.

Authors:  Ilaria Postiglione; Angela Chiaviello; Giuseppe Palumbo
Journal:  Med Oncol       Date:  2009-06-06       Impact factor: 3.064

7.  Reduced expression of GINS complex members induces hallmarks of pre-malignancy in primary untransformed human cells.

Authors:  Laura R Barkley; Ihn Young Song; Ying Zou; Cyrus Vaziri
Journal:  Cell Cycle       Date:  2009-05-23       Impact factor: 4.534

8.  PTIP regulates 53BP1 and SMC1 at the DNA damage sites.

Authors:  Jiaxue Wu; Marc J Prindle; Gregory R Dressler; Xiaochun Yu
Journal:  J Biol Chem       Date:  2009-05-04       Impact factor: 5.157

Review 9.  Double-strand break repair: 53BP1 comes into focus.

Authors:  Stephanie Panier; Simon J Boulton
Journal:  Nat Rev Mol Cell Biol       Date:  2013-12-11       Impact factor: 94.444

10.  Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control.

Authors:  François-Michel Boisvert; Ugo Déry; Jean-Yves Masson; Stéphane Richard
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.